Suggestions
Tom Donovan
Biotech communications consultant
Tom Donovan is the Founder of Lyrebird Consulting, a company specializing in biotechnology and communications.2 With a background in the biotech industry, Donovan brings extensive experience to his current role.
Professional Background
Prior to founding Lyrebird Consulting in 20202, Tom Donovan held leadership positions in the public biotech sector. He previously served as a function leader, reporting directly to the CEO and managing agency teams.1 This experience has provided him with valuable insights into the biotech industry and its communication needs.
Expertise and Services
Donovan's consultancy work involves:
- Strategic communications for the biotech industry3
- Investor relations
- Writing and media services
His scientific education and experience in investor relations contribute to his ability to deliver value across various partner needs.4
Additional Roles and Involvement
Beyond his work at Lyrebird Consulting, Tom Donovan is actively involved in the biotech community:
These roles demonstrate his commitment to fostering connections and support within the LGBTQ biotech executive community.
Online Presence
Tom Donovan maintains a professional presence on various platforms:
- LinkedIn: His profile can be found under the username tom-donovan-83a24b21
- Twitter: He uses the handle @apinchofNaCl, where he shares insights on biotech, strategic communications, and personal interests3
Through his consultancy work and community involvement, Tom Donovan has established himself as a respected figure in the biotechnology and communications sectors.
Highlights
Personal news update: I have moved to the UK and transitioned to independent consultancy, with ongoing part-time consulting to Ten Bridge Communications on special projects in the therapeutics space. I also look forward to new areas of work such as elevating emerging biotechnologies that tackle pressing global issues including sustainability and climate change. I will be maintaining my role on the Board of OUTbio and as a trustee of OUTbio UK.
Boston was the setting for a very special and rewarding chapter of my career and I'm proud to have worked with the world's leading therapeutics innovators in the heart of the biotech industry in Boston. My deep appreciation goes to Dan Quinn, Ann Stanesa, Stephanie Simon, Krystle Gibbs and Dean Wetherbee for the opportunity to learn from their expertise and be part of TBC's incredible growth. The team is always looking for the best talent and current positions are viewable at:
